-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
-
Summary
-
ELITE PHARMACEUTICALS INC /NV/ quarterly Lessee, Operating Lease, Liability, to be Paid, Year Three history and change rate from Q4 2021 to Q3 2025.
- ELITE PHARMACEUTICALS INC /NV/ Lessee, Operating Lease, Liability, to be Paid, Year Three for the quarter ending 30 Sep 2025 was $666,207, a 4.58% increase year-over-year.
Lessee, Operating Lease, Liability, to be Paid, Year Three, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, Year Three, YoY Quarterly Change (%)